FDA Investigator Ronald G Crawford
Ronald G Crawford has conducted inspections on 4 sites in 3 countries as of 09 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
09 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United Kingdom of Great Britain and Northern Ireland,
United States of America,
Switzerland
FDA Investigators that have inspected at least one site in common with Ronald G Crawford:
Adam R Cooke,
Adetutu M Gidado,
Azza Talaat,
Barbara Janine Breithaupt,
Brentley S Collins,
Catherine V Quinlan,
Charles I Ann,
Christian D Lynch (CDL),
Cynthia Jim, CSO,
Danial S Hutchison,
Daniel J Brown,
Darren S Morgan,
David J Gasparovich,
Dawn C Olenjack,
Edmund F Mrak, Jr,
Eliezar Ramos,
Emily J Orban,
Erika V Butler,
Gene D Arcy,
Geneve M Maxwell,
Geneve M Parks,
Gerald B Seaborn, Jr,
Helen B Ricalde,
Jacob G Lutz,
Jacqueline Mdiaz Albertini,
James K Ireland,
Janet L Bowen,
Jeffrey A Sommers,
Jeffrey D Meng,
José E Meléndez,
Julie D Bringger,
Junho Pak,
Katherine Szestypalow,
Kip J Hanks,
Larry K Austin,
Leslie A Paul,
Lindsey M Schwierjohann,
Martha Sullivan Myrick,
Matthew J Gretkierewicz,
Melissa J Garcia,
Michael E Maselli,
Michele L Forster, PhD,
Michele Perry Williams,
Miguel A Martinez Perez,
Mihaly S Ligmond,
Myra K Casey,
Patsy J Domingo,
Paul L Figarole, Jr,
Paula A Trost,
Philip A Klimkewicz,
Prabhu P Raju,
Ralph A Erickson,
Raymond R Roy, PhD,
Rebecca E Dombrowski,
Richard Ledwidge (nmi), PhD,
Robert C Coleman,
Robert M Barbosa,
Robert R Barbosa,
Rochelle K Kimmel,
Rose Ashley,
Russell J Glapion,
Sanket N Patel,
Sarah E Rhoades,
Sarah M Napier,
Sarah Rhoades,
Scott A Golladay,
Susan M Jackson,
Susan P Bruederle,
Susan T Hadman,
Terri L Dodds,
Thomas A Peter,
Thomas J Cosgrove,
Tonnie L Carter,
Tracey Asinjen Wiersma,
William D Tingley,
Zhong Li, PhD
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more